CANF
Can-Fite BioPharma
CANF
CANF
12 hedge funds and large institutions have $1.52M invested in Can-Fite BioPharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $1.62M → $1.52M (-$103K)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$264K | |
2 | +$59.4K | |
3 | +$5.03K | |
4 |
![]()
RhumbLine Advisers
Boston,
Massachusetts
|
+$3.11K |